Newspaper Advertisement of extract of unaudited financial results for the quarter ended on 31st December 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has informed BSE that it published an extract of its unaudited financial results for the quarter ended 31 December 2025 in newspapers, as required under SEBI Listing Regulations. The advertisements appeared in the English daily Free Press Journal and the Hindi newspaper Navbharat. The filing was made on 16 February 2026 and signed by Managing Director Nanjappan Aravind. No specific financial figures (revenue, profit, EPS) are disclosed in this particular filing — only the fact that the results were published in the newspapers. The detailed numbers would be in the earlier quarterly results filing submitted to the exchanges.
This is a routine compliance filing confirming newspaper publication of already-submitted quarterly results. No new financial information is being shared, so it is unlikely to have any direct impact on the stock price. Shareholders should look at the company's earlier Q3 FY26 results filing for the actual numbers.